Jung, Kyung Hae

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Mittendorf, E. A., Zhang, H., Barrios, C. H., Saji, S., Jung, K. H., Hegg, R., Koehler, A., Sohn, J., Iwata, H., Telli, M. L., et al. (2020) · The Lancet

Breast Cancer Treatment StudiesCancer Immunotherapy and Biomarkers

Cited by 1,083

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Tripathy, D., Im, S.-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S. A., Chow, L., Sohn, J., Lee, K. S., et al. (2018) · The Lancet Oncology

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 1,025

An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional cremophor EL-based paclitaxel for recurrent or metastatic HER2-negative breast cancer

Park, I. H., Sohn, J. H., Kim, S. B., Lee, K. S., Chung, J. S., Lee, S. H., Kim, T. Y., Jung, K. H., Cho, E. K., Kim, Y. S., et al. (2017) · Cancer Research and Treatment

Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery

Cited by 133

Depression Screening Using Daily Mental-Health Ratings from a Smartphone Application for Breast Cancer Patients

Kim, J., Lim, S., Min, Y. H., Shin, Y.-W., Lee, B., Sohn, G., Jung, K. H., Lee, J.-H., Son, B. H., Ahn, S. H., et al. (2016) · Journal of Medical Internet Research

Digital Mental Health InterventionsMobile Health and mHealth Applications

Cited by 85

A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors

Yun, Y. H., Kim, Y. A., Lee, M. K., Sim, J. A., Nam, B.-H., Kim, S., Lee, E. S., Noh, D.-Y., Lim, J.-Y., Kim, S., et al. (2017) · BMC Cancer

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 47

Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib

Tripathy, D., Im, S.-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S., Chow, L., Sohn, J., Lee, K. S., et al. (2021) · Cancer Research

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 30